AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...

As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, ...

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, ...

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Kim White's battle with adrenocortical carcinoma highlights her resilience and determination to live life fully despite her ...

When my daughter was diagnosed with breast cancer, writing our truth helped me and others face the harsh realities and ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data offering renewed hope for patients.